Skip to main content
The FDA has approved an extended-release form of zolpidem. The drug delivery system consists of a coated 2-layer tablet, one releases the drug immediately and the other provides a slower release. Zolpidem extended-release (zolpidem ER) is marketed by Sanofi-Synthelabo as Ambien CR™.

Pharmacology Update: Zolpidem Tartrate Extended Release Tablets (Ambien CR™)

October 30, 2005

The FDA has approved an extended-release form of zolpidem. The drug delivery system consists of a coated 2-layer tablet, one releases the drug immediately and the other provides a slower release. Zolpidem extended-release (zolpidem ER) is marketed by Sanofi-Synthelabo as Ambien CR.
Article Limit Reached

You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.

  • Award-winning Medical Content
  • Latest Advances & Development in Medicine
  • Unbiased Content
View Subscription Details

Already have an account? Log in